Bio-Techne Corp. buy UBS Group AG
Start price
06.11.25
/
50%
€50.50
Target price
06.11.26
€60.82
Performance (%)
-18.42%
Price
08.05.26
€41.04
Summary
This prediction is currently active. The prediction for Bio-Techne Corp. disappoints with a performance of -18.42%. A total of €0.16 was paid as dividends for this prediction. This prediction currently runs until 06.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -12.940% | -12.940% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at UBS Group AG from $65.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat